[{"id":"3cb9c529-b10e-4f91-95fe-9b98b824d0a5","acronym":"PCOX","url":"https://clinicaltrials.gov/study/NCT03638297","created_at":"2021-01-18T17:51:54.751Z","updated_at":"2024-07-02T16:35:33.322Z","phase":"Phase 2","brief_title":"PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer","source_id_and_acronym":"NCT03638297 - PCOX","lead_sponsor":"Sun Yat-sen University","biomarkers":" TMB • MSI","pipe":" | ","alterations":" TMB-H • MSI-H/dMMR","tags":["TMB • MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TMB-H • MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • BAT1306"],"overall_status":"Recruiting","enrollment":" Enrollment 29","initiation":"Initiation: 08/23/2018","start_date":" 08/23/2018","primary_txt":" Primary completion: 08/20/2022","primary_completion_date":" 08/20/2022","study_txt":" Completion: 08/31/2025","study_completion_date":" 08/31/2025","last_update_posted":"2023-10-17"},{"id":"7314ecf5-b124-470d-afc2-8ef412282820","acronym":"","url":"https://clinicaltrials.gov/study/NCT04151329","created_at":"2021-01-18T20:15:54.970Z","updated_at":"2024-07-02T16:36:53.955Z","phase":"Phase 1/2","brief_title":"A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor","source_id_and_acronym":"NCT04151329","lead_sponsor":"Bio-Thera Solutions","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BAT8001 • BAT1306"],"overall_status":"Unknown status","enrollment":" Enrollment 72","initiation":"Initiation: 06/21/2019","start_date":" 06/21/2019","primary_txt":" Primary completion: 12/31/2020","primary_completion_date":" 12/31/2020","study_txt":" Completion: 06/30/2021","study_completion_date":" 06/30/2021","last_update_posted":"2019-11-05"}]